Dysregulation of DYRK1B activity in the liver has been shown to affect glucose metabolism, leading to increased gluconeogenesis and elevated blood glucose levels, characteristic features of type 2 diabetes mellitus (Bhat et al., 2022; Bhat and Mani, 2023). The gene discussed is DYRK1B; the disease is type 2 diabetes mellitus.